Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 69 Prostatic Neoplasms 47 Breast Neoplasms 14 Sarcoma 10 Neoplasms 10 Endometrial Neoplasms 9 Vaginal Neoplasms 7 Esophageal Neoplasms 6 Uterine Neoplasms 4 Radiation Injuries 4 Lung Neoplasms 4 Liver Neoplasms 4 Glioblastoma 4 Carcinoma, Ductal, Breast 4 Adenocarcinoma 4 Vulvar Neoplasms 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Hyperthermia 3 Gliosarcoma 3 Desmoplastic Small Round Cell Tumor 3 Central Nervous System Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Brain Neoplasms 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Retinoblastoma 2 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2

Interventions

pembrolizumab 287 Nivolumab 258 Ipilimumab 236 Cyclophosphamide 135 aldesleukin 134 Interleukin-2 104 Temozolomide 75 Dacarbazine 74 trametinib 70 Vemurafenib 69 fludarabine 68 dabrafenib 65 fludarabine phosphate 62 sargramostim 44 binimetinib 44 Radiosurgery 44 Biopsy 43 Paclitaxel 42 Bevacizumab 42 incomplete Freund's adjuvant 39 encorafenib 37 Radiotherapy 36 Cisplatin 36 CTLA-4 Antigen 36 atezolizumab 35 Carboplatin 35 Magnetic Resonance Spectroscopy 33 cobimetinib 32 Specimen Handling 31 Introns 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Melanoma × Brachytherapy × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡